(no title)
scohesc | 1 year ago
Unless this antibody is somehow similar across all antibodies created as a reaction to an infection - that single patient should get a part of the profits from all vaccines/treatments derived from the antibody made in their body - it's only fair if their "work" is part of making vaccines that are then sold to others globally on a wide scale.
Then again, this is the medical industrial complex, so I'm sure they'll find a way to justify not reimbursing the patient. Unless I'm mistaken?
b112|1 year ago
The press release cites that they discovered it in one person, but it also doesn't say:
* how many people they were studying
* how they discovered this antibody
* after finding it, if they looked at others for it
It could be that literally 80% of the population has this antibody.
While the attempts to lockdown in various countries were a noble effort, my calculations indicate that basically everyone had been exposed to COVID prior to any vaccines being released. It just spread too fast regardless of efforts.
Various serological tests at the time showed high numbers of people with antibodies. This can be doubly highlighted by the fact that the vaccines had very low impact against strains they were not designed for, and COVID just mutates super fast.
(Had COVID vaccines been effective against strains they were not designed for, covid would have simply died out by now.)
I suspect almost everyone has been infected with dozens of COVID strains at this point. And that antibody optimization is a standard immune system defense.
Well, we'll see over the next few months re: this specific antibody.
John_Cena|1 year ago
Rhapso|1 year ago